The Schall Law Firm announces that it is investigating claims on the behalf of the investors in Alder BioPharmaceuticals, Inc. for potential breaches of fiduciary duty on the part of its directors in connection with the pending sale of the Company to H. Lundbeck A/S.

Alder is a biopharmaceutical company committed to transforming migraine treatment through the discovery, development and commercialisation of novel therapeutic antibodies. The company’s mission is to forever change migraine treatment and give people with migraine their lives back.

The Schall Law Firm represents investors injured by stock fraud, breaches of fiduciary duty, and other management and director malfeasance.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website, or by email at brian@schallfirm.com.

The Schall Law Firm represents investors on a contingency fee basis. We are a securities class action firm singularly committed to recovering shareholder money from publicly traded companies that committ fraud.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm represents investors on a contingency fee basis. We are a securities class action firm singularly committed to recovering shareholder money from publicly traded companies that commit fraud.